Supernus, Indivior to merge and form CNS-focused drugmaker
Supernus Pharmaceuticals and Indivior Pharmaceuticals have signed an all-stock merger agreement to establish a new company focused on CNS diseases. The combined company, which will be based in Rockville, MD, will keep the Supernus name ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.